MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

30 May 2022 Evaluate
The sales surged to Rs. 4762.33 millions, up 36.55% for the March 2022 quarter as against Rs. 3487.53 millions during the corresponding quarter previous year.The Total Profit for the quarter ended March 2022 of Rs. 116.58 millions grew from Rs.-409.60 millionsThe company reported a good operating profit of 496.70 millions compared to 302.61 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 4762.33 3487.53 36.55 16682.56 15428.96 8.12 16682.56 15428.96 8.12
Other Income 5.20 10.19 -48.97 112.93 27.22 314.88 112.93 27.22 314.88
PBIDT 496.70 302.61 64.14 1701.31 1129.49 50.63 1701.31 1129.49 50.63
Interest 174.31 256.46 -32.03 788.10 1120.32 -29.65 788.10 1120.32 -29.65
PBDT 322.39 -207.00 -255.74 913.21 -243.98 -474.30 913.21 -243.98 -474.30
Depreciation 142.57 150.08 -5.00 569.68 602.53 -5.45 569.68 602.53 -5.45
PBT 179.82 -357.08 -150.36 343.53 -846.51 -140.58 343.53 -846.51 -140.58
TAX 63.24 52.52 20.41 90.34 -115.04 -178.53 90.34 -115.04 -178.53
Deferred Tax 63.24 -33.34 -289.68 90.34 -200.90 -144.97 90.34 -200.90 -144.97
PAT 116.58 -409.60 -128.46 253.19 -731.47 -134.61 253.19 -731.47 -134.61
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 9.07 7.43 22.12 8.84 6.41 37.98 8.84 6.41 37.98
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..